The effect of flavonoids on the in vitro activity of antibiotics against St aphylococcus aureus By Tiza Lucy Ng’uni Thesis submitted in Fulfillment of the Requirements for the Degree Magister Scientiae MSc Medical Biosciences Faculty of Natural Sciences University of the Western Cape Supervisor: Professor BC Fielding Department of Medical Biosciences University of the Western Cape Co-Supervisor: Professor J Klaasen Department of Medical Biosciences University of the Western Cape November 2012 KEYWORDS Staphylococcus aureus Methicillin-resistant Staphylococcus aureus (MRSA) Multidrug resistance Flavonoids Antimicrobial susceptibility testing Combination studies Synergistic ratios Efflux pumps Efflux pump genes Polymerase Chain Reaction (PCR) ii ABSTRACT Staphylococcus aureus is a Gram-positive coccus belonging to the Stapylococcaeae family. S. aureus causes a wide range of infections that range from skin infections to life- threatening infections such as pneumonia and endocarditis and is the major cause of hospital and community-acquired infections. Despite antibiotics being available for the treatment of S. aureus infections, resistance to a number of antibiotics has developed over the years due to their improper and continuous use. S. aureus develops resistance to various drugs via different mechanisms, one of which is the extrusion of the antibiotics through efflux pumps that play a role in its acquisition of multidrug resistance. The ability of methicillin-resistant S. aureus to develop resistance to a variety of antibiotics is causing global concern as treatment options are being limited. Various antimicrobial studies carried out on purified plant-based flavonoids have shown that flavonoids enhance the antibacterial effect of antibiotics. This study analysed antibacterial effects of the antibiotics; tetracycline, ampicillin, methicillin and vancomycin and three flavonoids; chrysin, naringenin and 7-hydroxyflavone, against methicillin-sensitive ATCC 25923 (MSSA) and methicillin-resistant ATCC 33591 (MRSA) S. aureus strains, using the Kirby-Bauer disk diffusion and microtitre microdilution assays. In the Kirby- Bauer assay, the antibiotics demonstrated inhibitory effects on the growth of MSSA ATCC 25923. However MRSA ATCC 33591 was only susceptible to vancomycin, with minimal inhibition zones observed with ampicillin. The flavonoids did not enhance or reduce the antibacterial activities of the antibiotics as the zones of inhibition sizes remained unchanged in the combination studies. Microtitre assay results revealed that naringenin enhanced the antibacterial activities of the antibiotics tetracycline and ampicillin, against MSSA ATCC 25923 and MRSA 33591. This was evident as calculated synergistic ratios by the Abbot formula showed that naringenin had an additive effect. The presence of iii the efflux pump genes in MSSA ATCC 25923 and MRSA ATCC 33591 was compared using polymerase chain reaction (PCR). The mepA and gyrA genes were identified in both strains whereas sepA was identified in MRSA ATCC 33591. The presence of efflux pump genes in both MSSA ATCC 25923 and MRSA ATCC 33591 also confirmed that the presence or absence of the genes may contribute to antib iotic resistance. The presence of sepA in the MRSA and not the MSSA confirmed that this gene plays a role in conferring drug resistance. iv DECLARATION I, Tiza Lucy Ng’uni, declare that the thesis “The effect of flavonoids on the in vitro activity of antibiotics against Staphylococcus aureu s” is my own work, that it has not been submitted for any degree or examination in any other university, and that all the sources I have used or quoted have been indicated and acknowledged by complete references. Tiza Lucy Ng’uni Date............................................ Signed......................................... v DEDICATION This thesis is dedicated to my dad, Brig. Gen . Skinner Ng’uni, who passed away on 11th May, 2012. Words cannot describe the pain losing you has caused. Even though you are gone, you will always be loved and always be in our hearts. May Your Soul Rest In Eternal Peace. vi ACKNOWLEDGEMENTS I would firstly like to thank my God, for through Him all things are possible. I would not have been able to do all this without Him. I would like to thank my supervisor, Professor BC Fielding. Thank you so much for believing in me, supporting, encouraging and guiding me. You always go out of your way to ensure that your students are taken care of and for that I am truly grateful. You are the best supervisor one can ever ask for. I would also like to thank my co-supervisor, Professor JA Klaasen. Thank you for your encouragement and guidance. I truly appreciate the time and effort you put into helping me. To my virology lab colleagues, thank you for always being there and offering helping hands each time I needed you. I will be forever grateful. To my family, my mum Mrs Catherine Ng’uni, baby girl and siblings. No words can describe how much your support, love, encouragement, comfort and time means to me. Mum, you and dad contributed to making me the person that I am today. I love you all so much and I am truly grateful. I would also like to thank my friends, near and far, for all your support. I would like to thank the National Research Foundation (NRF) and the Department of Medical Biosciences, for the financial support and working space. vii TABLE OF CONTENTS TITLE PAGE i KEYWORDS ii ABSTRACT iii DECLARATION v DEDICATION vi ACKNOWLEDGEMENTS vii TABLE OF CONTENTS viii LIST OF ABBREVIATIONS xiii LIST OF FIGURES xvii LIST OF TABLES xix LIST OF APPENDICES xxi CHAPTER ONE: Literature Review 1.1. Introduction 1 1.1.1. Infection 1 1.1.2. Diagnosis and identification 2 1.2. Virulence factors 4 1.2.1. Toxins 4 1.2.1.1. Superantigens 5 1.2.1.2. Exfoliative toxins 5 1.2.1.3. Other toxins 6 viii 1.2.2. Protein A 6 1.2.3. Role of staphyloxanthin in virulence 7 1.3. Treatment 8 1.4. Methicillin- resistant Staphylococcus aureus (MRSA) 11 1.4.1. Global prevalence and incidence of MRSA 12 1.4.2. Hospital-acquired MRSA (HA-MRSA) 14 1.4.3. Community-acquired MRSA 15 1.4.4. Livestock-associated MRSA (LA-MRSA) 16 1.4.5. Antimicrobial resistance of MRSA 18 1.4.5.1. Mechanism of antibiotic resistance 19 1.4.5.2. Methicillin resistance 22 1.4.5.3. β-lactam resistance 22 1.4.5.4. Tetracycline resistance 23 1.4.5.5. Aminoglycoside resistance 24 1.4.5.6. Quinolone resistance 25 1.4.5.7. Vancomycin resistance 26 1.5. Prevention and control 28 1.6. Efflux pumps and efflux pump genes 29 1.6.1. Types of efflux pumps 30 1.6.1.1. Primary transporters 30 1.6.1.2. Secondary transporters 31 ix 1.6.2. Staphylococcus aureus efflux pumps and efflux pump genes 32 1.6.3. Role of MDR pumps in antibiotic drug re sistance 33 1.6.4. Efflux pump inhibitors 34 1.7. Antimicrobial activities of flavonoids 35 1.8. Aims of the study 39 1.9. References 40 CHAPTER TWO: Effects of flavonoids on the in vitro antibacterial activities of antibiotics against methicillin-sensitive and methicillin-resistant Staphylococcus aureus 2.1. Abstract 72 2.2. Introduction 73 2.3. Materials and Methods 76 2.3.1. Bacterial strains and growth conditions 76 2.3.2. Antibiotics and flavonoids 77 2.3.3. Antimicrobial susceptibility testing 77 2.3.3.1. Disk diffusion susceptibility test (Kirby-Bauer assay) 77 2.3.3.2. Microdilution susceptibility test (Microtitre assay) 79 2.3.4. Data analysis 81 2.4. Results 82 2.4.1. Antimicrobial susceptibility testing 82 2.4.1.1. Disk diffusion susceptibility test (Kirby-Bauer assay) 82 2.4.1.2. Microdilution susceptibility test (Microtitre assay) 85 2.5. Discussion 95 x
Description: